Healthcare & Life Sciences News and Articles

Google News – Pharmaceuticals External News

Indivior Pharmaceuticals Inc. (INDV) Down 5.3% Since Last Earnings Report: Can It Rebound? - Yahoo Finance

news.google.com · 02 Sep 2026

Google News – Pharmaceuticals External News

Roche licenses Simcere’s B-cell-targeting tri-specific for $1.53bn - Pharmaceutical Technology

news.google.com · 02 Sep 2026

Google News – Pharmaceuticals External News

5 Reasons To Buy Clinuvel Pharmaceuticals After Its Nasdaq Uplisting (NASDAQ:CUVL) - Seeking Alpha

news.google.com · 02 Sep 2026

Google News – Pharmaceuticals External News

Telix Pharmaceuticals (NASDAQ:TLX) Shares Gap Up - What's Next? - MarketBeat

news.google.com · 02 Sep 2026

Google News – Pharmaceuticals External News

Alnylam Pharmaceuticals gains as investors digest fresh ESC data and upcoming conference appearances - Quiver Quantitative

news.google.com · 02 Sep 2026

Google News – Clinical Trials External News

Avenzo Therapeutics to Participate in the Upcoming Wells Fargo 21st Annual Healthcare Conference - BioSpace

news.google.com · 02 Sep 2026

Google News – FDA (biotech/pharma) External News

FDA issues warning letters to five unapproved GLP-1 websites - pharmaphorum

news.google.com · 02 Sep 2026

Google News – Biopharma External News

Helix BioPharma Stock Slides 7.25% as Clinical Development Risk and Funding Uncertainty Pressure Sentiment - kalkine.ca

news.google.com · 02 Sep 2026

Google News – Pharmaceuticals External News

The Next Generation of Pharmaceutical Logistics: Personalization, Cold Chain Expansion and Elevated Resilience - Marken.

news.google.com · 02 Sep 2026

Google News – Pharmaceuticals External News

REGN Deadline Alert: Levi & Korsinsky Reminds Regeneron Pharmaceuticals (REGN) Investors of Securities Class Action Deadline on September 14, 2026 - prnewswire.com

news.google.com · 02 Sep 2026

Google News – Pharmaceuticals External News

SPRY Shareholder Alert: ARS Pharmaceuticals Inc. Securities Class Action Lawsuit - Investors Should Contact Levi & Korsinsky - prnewswire.com

news.google.com · 02 Sep 2026

Google News – Pharmaceuticals External News

Telix Pharmaceuticals Shares Rise 5.3% as Analyst Highlights BiPASS Trial and FDA Pathway - Yahoo Finance

news.google.com · 02 Sep 2026

Google News – FDA (biotech/pharma) External News

Pharmalittle: We're reading about a Huntington's gene therapy, Novo's challenges, and more - STAT

news.google.com · 02 Sep 2026

Google News – Pharmaceuticals External News

Are Investors Undervaluing Takeda Pharmaceutical Co. (TAK) Right Now? - finance.yahoo.com

news.google.com · 02 Sep 2026

Google News – Biopharma External News

This Under-the-Radar Biopharma Is Moving MIRA-55, a Non-Opioid Pain Drug That Outperformed Morphine Closer to the Clinic - Barchart.com

news.google.com · 02 Sep 2026

News & Articles

The Frontline Signal: Turning Daily Friction Into Better Healthcare Hiring

The Digital Health Interpreter: Making Technology Usable in Care

The Pitt is up for 25 Emmys - but the show's biggest fans are real-life doctors

From Roster to Resilience: Building a Workforce Risk Register

The Protocol-to-Workflow Specialist: A Career Emerging in Clinical Research

Jury should decide if university’s hiring process was tainted by diversity goals, court rules

Running costs of vaccine damage scheme more than double amount paid to victims

CMS expands TAVR Medicare coverage to asymptomatic patients

Stryker stock falls on slower peripheral vascular, hip sales

Veterans Affairs taps Amwell for telehealth revamp - Healthcare Dive

8 stories on the healthcare affordability crunch

Campaigners hold vigil as stroke unit closes

Epidural Kit Correction: Medical Action Industries Issues Correction for Epidural Kits Containing Spectra Medical Devices Lidocaine Ampules

UK needs new laws for AI in healthcare, says watchdog

Migraines and acne among five more conditions pharmacists can treat

Maternal Mental Health Policy

4 questions about the FDA’s approach to generative AI

Presidential dialogue on high-threat pathogens

5 takeaways from Oura’s IPO filing

Contractors will bear repair costs for lift defects at Queen Mary Hospital, Hong Kong development chief says

Indivior Pharmaceuticals Inc. (INDV) Down 5.3% Since Last Earnings Report: Can It Rebound? - Yahoo Finance

Roche licenses Simcere’s B-cell-targeting tri-specific for $1.53bn - Pharmaceutical Technology

5 Reasons To Buy Clinuvel Pharmaceuticals After Its Nasdaq Uplisting (NASDAQ:CUVL) - Seeking Alpha

Telix Pharmaceuticals (NASDAQ:TLX) Shares Gap Up - What's Next? - MarketBeat

Alnylam Pharmaceuticals gains as investors digest fresh ESC data and upcoming conference appearances - Quiver Quantitative

Avenzo Therapeutics to Participate in the Upcoming Wells Fargo 21st Annual Healthcare Conference - BioSpace

FDA issues warning letters to five unapproved GLP-1 websites - pharmaphorum

Helix BioPharma Stock Slides 7.25% as Clinical Development Risk and Funding Uncertainty Pressure Sentiment - kalkine.ca

The Next Generation of Pharmaceutical Logistics: Personalization, Cold Chain Expansion and Elevated Resilience - Marken.

REGN Deadline Alert: Levi & Korsinsky Reminds Regeneron Pharmaceuticals (REGN) Investors of Securities Class Action Deadline on September 14, 2026 - prnewswire.com

SPRY Shareholder Alert: ARS Pharmaceuticals Inc. Securities Class Action Lawsuit - Investors Should Contact Levi & Korsinsky - prnewswire.com

Telix Pharmaceuticals Shares Rise 5.3% as Analyst Highlights BiPASS Trial and FDA Pathway - Yahoo Finance

Pharmalittle: We're reading about a Huntington's gene therapy, Novo's challenges, and more - STAT

Are Investors Undervaluing Takeda Pharmaceutical Co. (TAK) Right Now? - finance.yahoo.com

This Under-the-Radar Biopharma Is Moving MIRA-55, a Non-Opioid Pain Drug That Outperformed Morphine Closer to the Clinic - Barchart.com